Khosla Ventures Acquisition Co - Ordinary Shares - Class A

NASDAQ:KVSA   3:59:40 PM EDT
9.87
-0.02 (-0.20%)
Equity Financing / Related, Initial Public Offerings

Valo Health And Khosla Ventures Acquisition Co. To Combine And Create Publicly Traded Company Focused On Transforming The Drug Discovery And Development Process

Published: 06/09/2021 12:31 GMT
Khosla Ventures Acquisition Co - Ordinary Shares - Class A (KVSA) - Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process.
Khosla Ventures Acquisition Co - Transaction Represents a Pro Forma Market Value of Approximately $2.8 Billion for Combined Company.
Khosla Ventures Acquisition Co - Valo Anticipates Pro Forma Cash Balance of Combined Company Will Be About $750 Million Before Expenses.
Khosla Ventures Acquisition Co - Deal Includes $168.5 Million Fully Committed Pipe From Leading Institutional Investors.
Khosla Ventures Acquisition - Samir Kaul to Join Valo's Board of Directors Following Completion of Business Combination.
Khosla Ventures Acquisition Co - Kvac Sponsor is Supporting Spac With a $25 Million Forward Purchase Agreement Backstop and Kvac Has No Warrants.